Serotonin promote liver regeneration following liver cancer treatment—but also supports early tumour regrowth

October 19, 2017
Credit: Medical University of Vienna

Blood platelets and serotonin – a molecule with growth promoting properties – stored in them play a significant role in the recurrence of cancer following partial hepatectomy. For the first time, a research group from MedUni Vienna has now proven these effects on tumour growth in humans. The results have recently been published in the Journal of Hepatology.

In a previous work dating from 2014, the group led by Patrick Starlinger from the Department of Surgery at Medical University of Vienna/Vienna General Hospital showed that high intra-platelet lead to a better clinical outcome following , since the serotonin stored in the platelets presumably has beneficial effects on post-operative regeneration, which subsequently might reduce the occurrence of complications. Based on this observation, it was hypothesised that influencing the serotonin level using drugs could boost liver regeneration and improve the outcome for patients following liver surgery. This concept would be very helpful in clinical routine, since approximately 10 – 20% of patients experience acute liver dysfunction following partial liver resection and there is currently no adequate treatment available.

Serotonin stimulates growth – both of the liver and the tumour

However, serotonin appears to be a relatively universal growth factor. Indeed, there are several scientific reports on the tumour-promoting effect of serotonin. In fact, numerous publications show that the main types of liver tumours display enhanced growth when stimulated with serotonin. However, there was only experimental data relating to this phenomenon and proof in the human system was still missing.

In order to evaluate the effect of serotonin on tumour growth in humans, patients undergoing liver resection were included in this study and serotonin levels in platelets were assessed before the operation. It has now been shown that patients with particularly low serotonin levels are more likely to suffer from complications and have a prolonged hospitalization after surgery than those with particularly high serotonin levels in their platelets.

However, if one looks at the recurrence rates for the resected tumours, the picture is very different: whereas patients with particularly high serotonin levels are more likely to experience early recurrence of cancer, those with very low serotonin levels are less likely to develop early tumor recurrence.

"The findings from this study are therefore of major importance for platelet-based treatment of post-operative liver failure," explains Patrick Starlinger, "While raising the amount of growth factors contained in the platelets, such as serotonin, has hitherto been regarded as an attractive treatment, we now see that this therapy also has a downside. Although higher serotonin levels reduce the risk of complications, in parallel, they increase the risk of developing early tumour recurrence within the first six months following liver resection with curative intent."

Serotonin was found to have this double-edged effect not only in primary liver tumours but also in metastases of colorectal cancer.

"These findings don't mean that platelet-based or -based treatment of post-operative liver failure should be abandoned completely" says Patrick Starlinger, clarifying the findings, "but rather the study shows that it is necessary to define the potential treatment very precisely and to evaluate the available options very carefully."

Explore further: Platelets promote the liver's regeneration process following surgery

More information: Robin Padickakudy et al. Bivalent role of intra-platelet serotonin in liver regeneration and tumor recurrence in humans, Journal of Hepatology (2017). DOI: 10.1016/j.jhep.2017.08.009

Related Stories

Platelets promote the liver's regeneration process following surgery

November 23, 2015
A team of researchers at the MedUni Vienna has discovered that certain platelet-derived growth factors are of major significance for the liver's regeneration processes. It has been shown that platelets can encourage the regrowth ...

Non-sex hormones in sexing liver cancers

August 7, 2017
NUS biologists have discovered that two hormone factors, cortisol and serotonin, play critical roles in the development of male-biased liver cancers.

Serotonin levels low in ankylosing spondylitis

October 3, 2015
(HealthDay)—Patients with ankylosing spondylitis (AS) have lower serotonin levels than healthy controls and patients with rheumatoid arthritis (RA), according to a study published online Sept. 30 in the Journal of Bone ...

Blood of SIDS infants contains high levels of serotonin

July 3, 2017
Blood samples from infants who died of Sudden Infant Death Syndrome (SIDS) had high levels of serotonin, a chemical that carries signals along and between nerves, according to a study funded in part by the National Institutes ...

Manipulating serotonin can promote healthy repair in chronic liver disease

November 28, 2011
(Medical Xpress) -- Publishing in the leading medical journal Nature Medicine, a team led by Newcastle University academics have identified serotonin receptors which can be targeted with drugs to enhance the natural healing ...

Depression is detectable in the blood

April 30, 2014
Researchers at the MedUni Vienna have demonstrated the possibility of using a blood test to detect depression. While blood tests for mental illnesses have until recently been regarded as impossible, a recent study clearly ...

Recommended for you

How defeating THOR could bring a hammer down on cancer

December 14, 2017
It turns out Thor, the Norse god of thunder and the Marvel superhero, has special powers when it comes to cancer too.

Researchers track muscle stem cell dynamics in response to injury and aging

December 14, 2017
A new study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) describes the biology behind why muscle stem cells respond differently to aging or injury. The findings, published in Cell Stem Cell, ...

'Human chronobiome' study informs timing of drug delivery, precision medicine approaches

December 13, 2017
Symptoms and efficacy of medications—and indeed, many aspects of the human body itself—vary by time of day. Physicians tell patients to take their statins at bedtime because the related liver enzymes are more active during ...

Estrogen discovery could shed new light on fertility problems

December 12, 2017
Estrogen produced in the brain is necessary for ovulation in monkeys, according to researchers at the University of Wisconsin-Madison who have upended the traditional understanding of the hormonal cascade that leads to release ...

Time of day affects severity of autoimmune disease

December 12, 2017
Insights into how the body clock and time of day influence immune responses are revealed today in a study published in leading international journal Nature Communications. Understanding the effect of the interplay between ...

3-D printed microfibers could provide structure for artificially grown body parts

December 12, 2017
Much as a frame provides structural support for a house and the chassis provides strength and shape for a car, a team of Penn State engineers believe they have a way to create the structural framework for growing living tissue ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.